Effect of Calcium + Vitamin D Supplementation on Weight Management in Very-low Calcium Consumers

NCT ID: NCT01447433

Last Updated: 2012-08-01

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

53 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-04-30

Study Completion Date

2012-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to determine whether calcium plus vitamin D supplementation is conducive to weight and fat loss during energy restriction in very-low calcium consumers.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Due to the contradicting findings in the hypothesis of calcium supplementation on weight and fat loss, which might be explained by the difference in initial calcium intake, the present study is aimed to evaluate the effect of calcium plus vitamin D supplementation on accelerating weight and fat loss in overweight or obese subjects with very-low calcium consumption(\<600mg/day).

The hypotheses to be tested are:

Calcium plus vitamin D supplementation is conducive to body weight and fat loss in overweight or obese young adults during energy restriction 12 weeks after randomization.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity Overweight

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Calcium Carbonate Vitamin D Body weight Body fat Metabolic parameters Energy restriction Very-low calcium consumers Obesity Overweight

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Calcium+D

Calcium supplements provide 600mg of calcium and 125IU vitamin D per day. A balanced diet contains 500kcal of caloric deficit based on daily energy expenditure.

Group Type EXPERIMENTAL

Calcium Carbonate

Intervention Type DRUG

tablet, 600mg elemental calcium and 125IU vitamin D, once daily, for 12 weeks

Energy restriction

Intervention Type BEHAVIORAL

A balanced diet contains 500kcal of caloric deficit based on daily energy expenditure.

Control

A balanced diet contains 500kcal of caloric deficit based on daily energy expenditure.

Group Type PLACEBO_COMPARATOR

Energy restriction

Intervention Type BEHAVIORAL

A balanced diet contains 500kcal of caloric deficit based on daily energy expenditure.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Calcium Carbonate

tablet, 600mg elemental calcium and 125IU vitamin D, once daily, for 12 weeks

Intervention Type DRUG

Energy restriction

A balanced diet contains 500kcal of caloric deficit based on daily energy expenditure.

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Caltrate® 600 + D Code:1007300

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male or female 18 to 25 years of age, generally healthy
* Habitual calcium intake below 600mg/d
* Overweight or obese (BMI between 24 and 35kg/m2, refer to the Chinese standard)
* Stable body weight (body weight change less than 1kg two months before screening)
* Less than 3 times of 20min of physical exercise per week
* Signed written informed consent

Exclusion Criteria

* Coronary heart disease, hypertension, diabetes; hepatic insufficiency or renal insufficiency, hyper- or hypothyroidism, mal-absorption, cholesterol concentrations requiring pharmaceutical treatment
* Pregnant or lactating woman
* Use of calcium supplements, oral antidiabetic agents, antihyperlipidemics or any other medications affecting metabolism 30 days before randomization
* Participating in another weight loss programs (i.e. taking oral pharmacotherapeutic agents and/or herbal preparations intended for the management of obesity; excessive physical activity; be on a diet)
* On special diets (i.e. vegetarian)
* Presently taking or have recently taken a prescription drug such as fluoroquinolone antibiotics, tetracycline, or levothyroxine (thyroid medication)
* Participating in another clinical trial 6 months before randomization
* Unlikely to be compliant (i.e. alcohol, drug abuse)
* Refusal or inability to give informed consent to participate in the study
Minimum Eligible Age

18 Years

Maximum Eligible Age

25 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Changhai Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Donglian Cai

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Donglian Cai, Master

Role: PRINCIPAL_INVESTIGATOR

Changhai Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Changhai Hospital

Shanghai, , China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

References

Explore related publications, articles, or registry entries linked to this study.

Zhu W, Cai D, Wang Y, Lin N, Hu Q, Qi Y, Ma S, Amarasekara S. Calcium plus vitamin D3 supplementation facilitated fat loss in overweight and obese college students with very-low calcium consumption: a randomized controlled trial. Nutr J. 2013 Jan 8;12:8. doi: 10.1186/1475-2891-12-8.

Reference Type DERIVED
PMID: 23297844 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

201011Z-02

Identifier Type: -

Identifier Source: org_study_id